A chemoinformatics search for peroxisome proliferator-activated receptors ligands revealed a new pan-agonist able to reduce lipid accumulation and improve insulin sensitivity
Sabina Sblano(University of Bari Aldo Moro), Fulvio Loiodice(University of Bari Aldo Moro), Aurélien Thomas(Hôpital Orthopédique de la Suisse Romande), Paolo Tortorella(University of Bari Aldo Moro), Paolo Paoli(University of Florence), Luca Piemontese(University of Bari Aldo Moro), Antonio Laghezza(University of Bari Aldo Moro), Alice Santi(European Society for Sexual Medicine), Rosalba Leuci(University of Bari Aldo Moro), Federica Gilardi(University of Milan), Massimo Genovese(University of Florence), Antonio Lavecchia(Federico II University Hospital), Leonardo Brunetti(University of Bari Aldo Moro), Carmen Cerchia(Federico II University Hospital)
Cited by 11
Related Papers
Morin: A Promising Natural Drug
|Current Medicinal Chemistry|2016|249
Cancer Associated Fibroblasts: The Architects of Stroma Remodeling
|PROTEOMICS|2017|247
Tumor matrix stiffness promotes metastatic cancer cell interaction with the endothelium
|The EMBO Journal|2017|201
The insulin-mimetic effect of Morin: A promising molecule in diabetes treatment
|Biochimica et Biophysica Acta (BBA) - General Subjects|2013|134
Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity
|Nature Communications|2017|119